Sofía Sánchez‐Iglesias

977 total citations
39 papers, 704 citations indexed

About

Sofía Sánchez‐Iglesias is a scholar working on Molecular Biology, Physiology and Neurology. According to data from OpenAlex, Sofía Sánchez‐Iglesias has authored 39 papers receiving a total of 704 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 7 papers in Physiology and 5 papers in Neurology. Recurrent topics in Sofía Sánchez‐Iglesias's work include Nuclear Structure and Function (23 papers), RNA Research and Splicing (15 papers) and RNA regulation and disease (7 papers). Sofía Sánchez‐Iglesias is often cited by papers focused on Nuclear Structure and Function (23 papers), RNA Research and Splicing (15 papers) and RNA regulation and disease (7 papers). Sofía Sánchez‐Iglesias collaborates with scholars based in Spain, United States and Italy. Sofía Sánchez‐Iglesias's co-authors include Ramón Soto‐Otero, Estefanı́a Méndez-Álvarez, David Araújo‐Vilar, José L. Labandeira‐García, Javier Iglesias‐González, Ana Muñoz, P. Rey, Antía Fernández‐Pombo, Inés Sánchez‐Sellero and Rosario Domingo‐Jiménez and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and International Journal of Molecular Sciences.

In The Last Decade

Sofía Sánchez‐Iglesias

38 papers receiving 696 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sofía Sánchez‐Iglesias Spain 14 388 137 124 98 98 39 704
Rabab H. Sayed Egypt 19 308 0.8× 99 0.7× 139 1.1× 85 0.9× 46 0.5× 54 828
Min-Ju Kim South Korea 18 286 0.7× 137 1.0× 101 0.8× 52 0.5× 34 0.3× 46 670
Jaime M. Merino Spain 18 636 1.6× 160 1.2× 197 1.6× 21 0.2× 61 0.6× 41 1.2k
Jianzong Chen China 16 516 1.3× 87 0.6× 99 0.8× 136 1.4× 93 0.9× 17 830
Dinesh K. Dhull India 13 284 0.7× 135 1.0× 127 1.0× 57 0.6× 71 0.7× 15 837
Navneet Ammal Kaidery United States 15 586 1.5× 153 1.1× 161 1.3× 200 2.0× 61 0.6× 21 964
Ekaterina Turlova Canada 15 308 0.8× 76 0.6× 89 0.7× 66 0.7× 102 1.0× 21 842
Kwan–Hoon Moon United States 18 542 1.4× 172 1.3× 116 0.9× 45 0.5× 34 0.3× 21 1.1k
Jui‐Sheng Wu Taiwan 15 545 1.4× 144 1.1× 80 0.6× 42 0.4× 34 0.3× 23 993
Jian-Guo Cui United States 17 346 0.9× 410 3.0× 143 1.2× 57 0.6× 101 1.0× 28 862

Countries citing papers authored by Sofía Sánchez‐Iglesias

Since Specialization
Citations

This map shows the geographic impact of Sofía Sánchez‐Iglesias's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sofía Sánchez‐Iglesias with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sofía Sánchez‐Iglesias more than expected).

Fields of papers citing papers by Sofía Sánchez‐Iglesias

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sofía Sánchez‐Iglesias. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sofía Sánchez‐Iglesias. The network helps show where Sofía Sánchez‐Iglesias may publish in the future.

Co-authorship network of co-authors of Sofía Sánchez‐Iglesias

This figure shows the co-authorship network connecting the top 25 collaborators of Sofía Sánchez‐Iglesias. A scholar is included among the top collaborators of Sofía Sánchez‐Iglesias based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sofía Sánchez‐Iglesias. Sofía Sánchez‐Iglesias is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fernández‐Pombo, Antía, İlgın Yıldırım Şimşir, Sofía Sánchez‐Iglesias, et al.. (2024). A cohort analysis of familial partial lipodystrophy from two Mediterranean countries. Diabetes Obesity and Metabolism. 26(11). 4875–4886. 2 indexed citations
2.
Sánchez‐Iglesias, Sofía, et al.. (2024). Lipodystrophic Laminopathies: From Dunnigan Disease to Progeroid Syndromes. International Journal of Molecular Sciences. 25(17). 9324–9324.
3.
Fernández‐Pombo, Antía, et al.. (2023). Clinical Spectrum of LMNA-Associated Type 2 Familial Partial Lipodystrophy: A Systematic Review. Cells. 12(5). 725–725. 14 indexed citations
4.
Fernández‐Pombo, Antía, et al.. (2023). Clinical Characterisation and Comorbidities of Acquired Generalised Lipodystrophy: A 14-Year Follow-Up Study. Journal of Clinical Medicine. 12(23). 7344–7344. 2 indexed citations
5.
Fernández‐Pombo, Antía, et al.. (2023). Natural history and comorbidities of generalised and partial lipodystrophy syndromes in Spain. Frontiers in Endocrinology. 14. 1250203–1250203. 8 indexed citations
6.
Sánchez‐Iglesias, Sofía, Alberto Rábano, Ana Senra, et al.. (2023). A murine model of BSCL2-associated Celia's encephalopathy. Neurobiology of Disease. 187. 106300–106300. 1 indexed citations
7.
Araújo‐Vilar, David, Antía Fernández‐Pombo, Berta Victoria, et al.. (2021). Variable Expressivity and Allelic Heterogeneity in Type 2 Familial Partial Lipodystrophy: The p.(Thr528Met) LMNA Variant. Journal of Clinical Medicine. 10(7). 1497–1497. 6 indexed citations
8.
Araújo‐Vilar, David, Sofía Sánchez‐Iglesias, Ana I. Castro, et al.. (2021). Variable Expressivity in Type 2 Familial Partial Lipodystrophy Related to R482 and N466 Variants in the LMNA Gene. Journal of Clinical Medicine. 10(6). 1259–1259. 4 indexed citations
9.
Fernández‐Pombo, Antía, et al.. (2021). Familial partial lipodystrophy syndromes. La Presse Médicale. 50(3). 104071–104071. 12 indexed citations
10.
Sánchez‐Iglesias, Sofía, Antía Fernández‐Pombo, Á. Hermida Ameijeiras, et al.. (2021). Celia’s Encephalopathy (BSCL2-Gene-Related): Current Understanding. Journal of Clinical Medicine. 10(7). 1435–1435. 11 indexed citations
11.
Araújo‐Vilar, David, Antía Fernández‐Pombo, Gemma Rodríguez-Carnero, et al.. (2020). LipoDDx: a mobile application for identification of rare lipodystrophy syndromes. Orphanet Journal of Rare Diseases. 15(1). 81–81. 5 indexed citations
12.
Fernández‐Marmiesse, Ana, Sofía Sánchez‐Iglesias, Alejandra Darling, et al.. (2019). A de novo heterozygous missense BSCL2 variant in 2 siblings with intractable developmental and epileptic encephalopathy. Seizure. 71. 161–165. 8 indexed citations
13.
Sánchez‐Iglesias, Sofía, Lucía Ordóñez Mayán, Marcos Pazos-Couselo, et al.. (2016). Type 1 familial partial lipodystrophy: understanding the Köbberling syndrome. Endocrine. 54(2). 411–421. 42 indexed citations
14.
Ruiz‐Riquelme, Alejandro, Sofía Sánchez‐Iglesias, Alberto Rábano, et al.. (2015). Larger aggregates of mutant seipin in Celia's Encephalopathy, a new protein misfolding neurodegenerative disease. Neurobiology of Disease. 83. 44–53. 13 indexed citations
15.
Soto‐Otero, Ramón, Estefanı́a Méndez-Álvarez, Sofía Sánchez‐Iglesias, et al.. (2012). 2‐Benzazepine Nitrones Protect Dopaminergic Neurons against 6‐Hydroxydopamine‐Induced Oxidative Toxicity. Archiv der Pharmazie. 345(8). 598–609. 13 indexed citations
16.
Iglesias‐González, Javier, Sofía Sánchez‐Iglesias, Estefanı́a Méndez-Álvarez, et al.. (2012). Differential Toxicity of 6-Hydroxydopamine in SH-SY5Y Human Neuroblastoma Cells and Rat Brain Mitochondria: Protective Role of Catalase and Superoxide Dismutase. Neurochemical Research. 37(10). 2150–2160. 34 indexed citations
17.
Sánchez‐Iglesias, Sofía, Estefanı́a Méndez-Álvarez, Javier Iglesias‐González, et al.. (2009). Brain oxidative stress and selective behaviour of aluminium in specific areas of rat brain: potential effects in a 6‐OHDA‐induced model of Parkinson’s disease. Journal of Neurochemistry. 109(3). 879–888. 65 indexed citations
18.
Sánchez‐Iglesias, Sofía, Ramón Soto‐Otero, Javier Iglesias‐González, et al.. (2007). Analysis of brain regional distribution of aluminium in rats via oral and intraperitoneal administration. Journal of Trace Elements in Medicine and Biology. 21. 31–34. 48 indexed citations
19.
Sánchez‐Iglesias, Sofía, P. Rey, Estefanı́a Méndez-Álvarez, José L. Labandeira‐García, & Ramón Soto‐Otero. (2006). Time-Course of Brain Oxidative Damage Caused by Intrastriatal Administration of 6-Hydroxydopamine in a Rat Model of Parkinson’s Disease. Neurochemical Research. 32(1). 99–105. 42 indexed citations
20.
Rey, P., et al.. (2006). Angiotensin type-1-receptor antagonists reduce 6-hydroxydopamine toxicity for dopaminergic neurons. Neurobiology of Aging. 28(4). 555–567. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026